Cargando…

Targeting Peripheral N-Methyl-D-Aspartate Receptor (NMDAR): A Novel Strategy for the Treatment of Migraine

Backgrounds: Several acute and preventive medications were developed for the treatment of migraine. Yet, a significant proportion of patients reports an inadequate response and a lack of tolerability, emphasizing the need for new options. Glutamate is the most important excitatory neurotransmitter i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalatharan, Veberka, Al-Karagholi, Mohammad Al-Mahdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055974/ https://www.ncbi.nlm.nih.gov/pubmed/36983158 http://dx.doi.org/10.3390/jcm12062156

Ejemplares similares

The vascular role of CGRP: a systematic review of human studies
por: Al-Karagholi, Mohammad Al-Mahdi, et al.
Publicado: (2023)

Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy
por: Chen, Shuang, et al.
Publicado: (2022)

Anti-n-Methyl-d-Aspartate-Receptor (NMDAR) Encephalitis in Association with Ovarian Teratoma
por: Ahmad, Javaad, et al.
Publicado: (2017)

38.3 ONGOING GERMINAL CENTRE REACTIONS CONTRIBUTE TO N-METHYL-D-ASPARTATE RECEPTOR (NMDAR) ANTIBODY PRODUCTION IN NMDAR-ANTIBODY ENCEPHALITIS
por: Makuch, Mateusz, et al.
Publicado: (2018)

Current Progress on Assessing the Prognosis for Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis
por: Wang, Hao, et al.
Publicado: (2020)

Anti N-methyl-D-aspartate receptor (NMDAr) encephalitis during pregnancy: A case report
por: Dono, Fedele, et al.
Publicado: (2022)

Case Report: Cotard's Syndrome in Anti-N-methyl D-aspartate (NMDA) Receptor (Anti-NMDAR) Encephalitis
por: Taib, Nur Iwana Abdul, et al.
Publicado: (2022)

Involvement of Potassium Channel Signalling in Migraine Pathophysiology
por: Al-Karagholi, Mohammad Al-Mahdi
Publicado: (2023)

NYX‐2925 induces metabotropic N‐methyl‐d‐aspartate receptor (NMDAR) signaling that enhances synaptic NMDAR and α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor
por: Bowers, M. Scott, et al.
Publicado: (2019)

Mechanosensitivity of N-methyl-D-aspartate receptors (NMDAR) is the key through which amyloid beta oligomers activate them
por: Fani, Giulia, et al.
Publicado: (2021)

Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis Associated With Mediastinal and Ovarian Teratomas: A Case Report
por: Lee, Sue Hyun, et al.
Publicado: (2023)

Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma
por: Tamura, Hajime, et al.
Publicado: (2011)

Prion Protein Is a Key Determinant of Alcohol Sensitivity through the Modulation of N-Methyl-D-Aspartate Receptor (NMDAR) Activity
por: Petit-Paitel, Agnès, et al.
Publicado: (2012)

An Ensemble Approach to Predict Schizophrenia Using Protein Data in the N-methyl-D-Aspartate Receptor (NMDAR) and Tryptophan Catabolic Pathways
por: Lin, Eugene, et al.
Publicado: (2020)

Overlapping anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis with neuromyelitis optica spectrum disorders: a case report
por: Pan, Jialin, et al.
Publicado: (2022)

Inhibition of NR2B-Containing N-methyl-D-Aspartate Receptors (NMDARs) in Experimental Autoimmune Encephalomyelitis, a Model of Multiple Sclerosis
por: Farjam, Mojtaba, et al.
Publicado: (2014)

The K(ATP) channel in migraine pathophysiology: a novel therapeutic target for migraine
por: Al-Karagholi, Mohammad Al-Mahdi, et al.
Publicado: (2017)

14-3-3 proteins promote synaptic localization of N-methyl d-aspartate receptors (NMDARs) in mouse hippocampal and cortical neurons
por: Lee, Gloria S., et al.
Publicado: (2021)

GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases
por: Ladagu, Amany Digal, et al.
Publicado: (2023)

Anti-N-methyl-D-aspartate receptor(NMDAR) antibody encephalitis presents in atypical types and coexists with neuromyelitis optica spectrum disorder or neurosyphilis
por: Qin, Kaiyu, et al.
Publicado: (2017)

Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate Receptors
por: Bettini, Ezio, et al.
Publicado: (2022)

Clinical Features, Treatment, and Outcomes Among Chinese Children With Anti-methyl-D-aspartate Receptor (Anti-NMDAR) Encephalitis
por: Zhang, Min, et al.
Publicado: (2019)

The role of high‐conductance calcium‐activated potassium channel in headache and migraine pathophysiology
por: Al‐Karagholi, Mohammad Al‐Mahdi, et al.
Publicado: (2022)

Anti-N-methyl-D-aspartate Receptor Encephalitis
por: Tanquary, Gregory, et al.
Publicado: (2019)

Involvement of adenosine signaling pathway in migraine pathophysiology: a systematic review of preclinical studies
por: Thuraiaiyah, Janu, et al.
Publicado: (2022)

NMDA Receptors in Health and Diseases: New Roles and Signaling Pathways—Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Autoantibodies as Potential Biomarkers of Fatigue in Patients with Rheumatic Diseases
por: Marinoska, Tatjana, et al.
Publicado: (2023)

Portrayal of a young woman in 16(th) century Islamic art: Does she have anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis?
por: Kondziella, Daniel, et al.
Publicado: (2018)

The Spectrum of Movement Disorders in Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis Both in Children and Adults: An Experience From a Single Tertiary Care Center
por: Haq, Ayaz Ul, et al.
Publicado: (2021)

Pediatric anti-N methyl D aspartate receptor encephalitis
por: Suri, Vinit, et al.
Publicado: (2013)

Pediatric N-Methyl-D-Aspartate Receptor Autoimmune Encephalitis
por: Uvais, N. A.
Publicado: (2018)

Protein quality control of N-methyl-D-aspartate receptors
por: Benske, Taylor M., et al.
Publicado: (2022)

Symptomatic treatments of N-methyl-D-aspartate receptor encephalitis
por: Lee, Soon-Tae
Publicado: (2021)

Symptomatologic pathomechanism of N-methyl D-aspartate receptor encephalitis
por: Lee, Woo-Jin
Publicado: (2021)

Second messenger signalling bypasses CGRP receptor blockade to provoke migraine attacks in humans
por: Do, Thien Phu, et al.
Publicado: (2023)

Regulatory T cell profiles in patients with N-methyl-ᴅ-aspartate receptor-antibody encephalitis
por: Iro, Mildred A., et al.
Publicado: (2023)

Effect of N-Methyl-D-Aspartate Receptor Antagonist Dextromethorphan on Opioid Analgesia in Pediatric Intensive Care Unit
por: Naeem, Mohammed, et al.
Publicado: (2016)

Ionic permeability characteristics of the N-methyl-D-aspartate receptor channel
Publicado: (1994)

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
por: Weickert, C S, et al.
Publicado: (2013)

Long-term potentiation and the role of N-methyl-d-aspartate receptors
por: Volianskis, Arturas, et al.
Publicado: (2015)

Early Intervention for Psychosis with N-Methyl-D-Aspartate Receptor Modulators
por: Dong, Chao, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v1hvkf89ibd21v54l9mcfuno5e